Compared to other wireless professional mice, Apple's entry is certainly intuitive with its multi-touch interface, removing ...

Batten disease is a rare inherited condition that affects brain development and function. CLN3 disease is the most common ...

Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat ...

Announced class-leading data from diet-induced obesity (DIO) mouse model with NMRA-215, a potentially best-in-class, highly brain-penetrant, oral ...

Radiant Biotherapeutics to present new data from lead oncology programme at SITC 2025 annual meeting: Toronto Thursday, November 6, 2025, 18:00 Hrs [IST] Radiant Biotherapeutics, ...

A histology showing the ankle joint of a mouse four days after receiving the new antibody treatment, V11 sFc (Ravetch lab) Intravenous immunoglobulin ...

Montai will present data for the first time on its novel oral NRF2 agonist molecule, MTAI-1025, for ulcerative colitis (UC) ...

A new study out of Dalhousie University has found microplastics in the meat of lobsters caught off the coast of Nova Scotia.

The system uses a biodegradable chitosan-based hydrogel combined with lipid-coated microparticles that release ...

Leucine-rich repeat–containing protein 15 (LRRC15) is a cell surface protein that has emerged as a significant biomarker in cancer biology. This protein is minimally expressed in normal healthy tissue ...

Prothena today reported financial results for the third quarter and first nine months of 2025 and provided business highlights.

Financial Results for the Third Quarter 2025 Cash, cash equivalents and investments totaled $99.1 million as of September 30, 2025, compared with $56.9 million as of December 31, 2024. Our cash, cash ...